Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,340,560 Process for esterifying silicon-halogen compounds in a column and apparatus suitable therefor
What is described is a process for continuously esterifying halosilanes of the formula I with alcohols of the formula II to give silane esters of the formula...
US-9,340,559 Proteasome inhibitor delanzomib for use in the treatment of lupus
The present invention provides a method for treating lupus in a subject, comprising the step of administering to the subject Compound A. ##STR00001##
US-9,340,558 Filamin a binding anti-inflammatory and analgesic
A compound or its pharmaceutically acceptable salt, optionally including both individual enantiomeric forms, a racemate, diastereomers and mixtures thereof,...
US-9,340,557 Substituted quinoxaline DNA-PK inhibitors
The compounds represented by Formula (I) and pharmaceutically acceptable salts thereof are useful as inhibitors of DNA-PK: ##STR00001## where each of R.sup.1,...
US-9,340,556 Antibacterial compounds
The present invention relates to cephalosporin antibacterial compounds of Formula (I): ##STR00001## or corresponding pharmaceutically acceptable salts...
US-9,340,555 Compounds as tyrosine kinase modulators
The present invention is directed to novel compounds of Formula I. The compounds of the present invention are potent tyrosine kinase modulators, and are...
US-9,340,554 IRAK inhibitors and uses thereof
The present invention provides 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine compounds and pharmaceutical compositions thereof as inhibitors of IRAK.
US-9,340,553 Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR
Compounds of Formula (A) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by pharmaceutical...
US-9,340,552 Method of making isoidide
Disclosed is a process for the preparation of isoidide from isosorbide. An aqueous solution of isosorbide is subjected to epimerization in the presence of...
US-9,340,551 Inhibitors of bacterial type III secretion system
Organic compounds showing the ability to inhibit effector toxin secretion or translocation mediated by bacterial type III secretion systems are disclosed. The...
US-9,340,550 Methods for one-pot N-demethylation/N-functionalization of morphine and tropane alkaloids
The present invention provides a method for the N-demethylation and N-functionalization of an N-methylated heterocycle such as a morphine alkaloid or tropane...
US-9,340,549 Oxazolidinone compounds and derivatives thereof
Compounds of Formula (I) and Formula (II) are useful inhibitors of tankyrase. Compounds of Formula (I) and Formula (II) have the following structure: where the...
US-9,340,548 Substituted pyrazolo[3,4-a]carbazoles as hepatitis C inhibitors
The invention relates to compounds of Formula (I) ##STR00001## and pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4...
US-9,340,547 Pyrrolotriazinone derivatives as inhibitors P13K
New pyrrolotriazinone derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical...
US-9,340,546 Compounds useful as inhibitors of ATR kinase
The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions...
US-9,340,545 Quinazolin-4 (3H)--one derivatives used as P13 kinase inhibitors
The present invention relates to the compound of formula (I) ##STR00001## and to compositions comprising the same and to the use of the compound and to...
US-9,340,544 Purinyl derivatives and their use as potassium channel modulators
This invention relates to novel purinyl derivatives and their use as potassium channel modulating agents. Moreover the invention is directed to pharmaceutical...
US-9,340,543 Helquat derivatives, preparation thereof, and use thereof as medicaments
The invention provides helquat derivatives of general formula I, wherein substituents R.sup.1 and R.sup.2 are independently selected from a group comprising H...
US-9,340,542 Propellane-based compounds and the use thereof
The application is directed to compounds of Formula I ##STR00001## and pharmaceutically acceptable salts and solvates thereof, wherein R.sup.1-R.sup.5 are...
US-9,340,541 Preparation of nematocidal sulfonamides
Disclosed is a method for preparing a compound of Formula 1 by coupling of intermediates of Formula 2 and Formula 3 in the presence of an aluminum reagent of...
US-9,340,540 TYK2 inhibitors and uses thereof
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated...
US-9,340,539 Hepatitis C inhibitor compounds
A compound of formula (I) useful for the treatment or prevention of hepatitis C viral infection, (Formula (I)) wherein: X.sup.1 and X.sup.2 are each...
US-9,340,538 Dihydropyrimidine compounds and their application in pharmaceuticals
Provided herein are dihydropyrimidine compounds and their pharmaceutical applications, especially for use in treating and preventing HBV diseases. Specifically,...
US-9,340,537 Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
The present invention relates to compounds of formula (I): in which Y, Y, R, R 2, R 3 and R 4 are defined in the Summary of the Invention; capable of inhibiting...
US-9,340,536 Multicomponent crystals comprising dasatinib and selected co-crystal formers
Provided are a multicomponent crystalline system (co-crystal), use thereof, as well as a process for obtaining the same. The said multicomponent crystalline...
US-9,340,535 N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl- )phenyl]acetamide mesylate monohydrate
The present invention relates to an improved and shortened synthesis of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridiny- ...
US-9,340,534 Compounds and methods for treating ocular diseases
Described herein are compounds of formula I ##STR00001## compositions and methods for the treatment of diseases affecting the eye, including glaucoma or...
US-9,340,533 1,4-benzothiazepine-1-oxide derivative and pharmaceutical composition utilizing the same
Provided are novel compound that is useful as a treatment agent or a prophylactic agent for cardiac failure, cardiac failure due to dystelectasis, left...
US-9,340,532 Methods and compositions for inhibiting CNKSR1
Embodiments include compositions and methods of inhibiting CNKSR1 and methods of identifying inhibitors of CNKSR1.
US-9,340,531 Cycloalkyl-substituted imidazole derivative
A compound represented by the following general formula (I) or a pharmacologically acceptable salt thereof, wherein A represents a C3 to C12 cycloalkyl group...
US-9,340,530 Preparation and use of bicyclic himbacine derivatives as PAR-1 receptor antagonists
The present invention relates to bicyclic himbacine derivatives of the formula or a pharmaceutically acceptable salt thereof, wherein: X is --O--, --N(R),...
US-9,340,529 Triazolones as fatty acid synthase inhibitors
This invention relates to the use of triazolone derivatives for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS)....
US-9,340,528 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
The present invention relates to substituted aminoquinoxaline compounds of general formula (I) in which (II), R.sup.2, R.sup.3, R.sup.4, R.sup.6, R.sup.7, n and...
US-9,340,527 S1P modulating agents
Compounds of formula (I) or (II) can modulate the activity of SIP receptors.
US-9,340,526 Process for preparing pyridyl-substituted pyrazoles
The present invention relates to a process for preparing 1-pyridyl-substituted pyrazoles, comprising the reaction of acetyleneketones with pyridylhydrazine...
US-9,340,525 Stem cell cultures
The present invention relates compounds for stabilizing cells and methods of their use.
US-9,340,524 Androgen receptor modulator and uses thereof
Described herein is the androgen receptor modulator of formula (I) ##STR00001## in the treatment of prostate cancer in combination with other therapeutic...
US-9,340,523 Certain dipeptidyl peptidase inhibitors
Provided are certain dipeptidyl peptidase inhibitors, pharmaceutical compositions thereof, and methods of use therefor.
US-9,340,522 Pyrazolone-derivatives and their use as PDE-4 inhibitors
The compounds of Formula (I), ##STR00001## are novel effective inhibitors of the type 4 phosphodiesterase.
US-9,340,521 Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives
The present invention relates to a method for dual inhibition of sodium-dependent glucose cotransporter 1 (SGLT1) and sodium-dependent glucose cotransporter 2...
US-9,340,520 Hepatitis C virus inhibitors
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical...
US-9,340,519 Paracyclophane-based ligands, their preparation and use in catalysis
A substituted paracyclophane of formula (I) is provided ##STR00001## wherein X.sup.1 and X.sup.2 are linking groups comprising between 2 to 4 carbon atoms,...
US-9,340,518 Process for the preparation of (2Z,5Z)-5-(3-chloro-4-((R)-2,3-dihydroxypropdxy)benzylidene)-2-(propylimi- ...
The present invention relates to a new process for the preparation of (2Z,5Z)-5-(3-chloro-4-((R)-2,3-dihydroxypropoxy)benzylidene)-2-(propylimi- ...
US-9,340,517 Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor
The present invention provides compounds of Formula (I) that are useful for modulating the biological activity of the melanocortin-5 receptor (MC5R). Compounds...
US-9,340,516 Form-II crystal of 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsu- lfonyl)...
Form-II crystal of 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsu- lfonyl)acetamide and a method of producing the crystal are...
US-9,340,515 Pure erlotinib
The present invention relates to processes for the preparation of erlotinib and salts and polymorphs thereof preparable by said processes, to medical uses of...
US-9,340,514 Inhibitors of the fibroblast growth factor receptor
Described herein are inhibitors of FGFR, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions to inhibit...
US-9,340,513 Propenoate derivatives of betulin
The present invention relates to a compound characterized by the following Formula I: ##STR00001## or a pharmaceutically acceptable salt thereof, wherein X,...
US-9,340,512 Morphinan compounds
This invention relates to novel morphinan compounds and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a...
US-9,340,511 Process for making isoquinoline compounds
The present invention relates to methods for making isoquinoline compounds and the intermediate compounds achieved thereby. Such compounds can be used to...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.